Quantinno Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Quantinno Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10M	Buy	296,251 +79,790	+37%	+$2.66M	0.01%	983
2026 Q1	$6.52M	Buy	216,461 +25,349	+13%	+$816K	0.01%	1035
2025 Q4	$5.96M	Buy	191,112 +33,892	+22%	+$835K	0.01%	973
2025 Q3	$3.18M	Buy	157,220 +79,716	+103%	+$1.4M	0.01%	1072
2025 Q2	$1.3M	Buy	77,504 +23,471	+43%	+$379K	0.01%	1229
2025 Q1	$830K	Buy	54,033 +10,936	+25%	+$195K	0.01%	1207
2024 Q4	$950K	Buy	43,097 +6,952	+19%	+$126K	0.01%	1062
2024 Q3	$651K	Buy	36,145 +9,269	+34%	+$162K	0.01%	1058
2024 Q2	$437K	Buy	26,876 +8,050	+43%	+$124K	0.01%	1066
2024 Q1	$266K	Buy	18,826 +6,497	+53%	+$81.9K	0.01%	1113
2023 Q4	$129K	Buy	+12,329	New	+$115K	﹤0.01%	1066

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Quantinno Capital Management's TEVA Position: Q2 2026 in Review

Quantinno Capital Management increased its Teva Pharmaceuticals (TEVA) stake by 37% in Q2 2026, buying an estimated $2.66M and bringing the position to 296,251 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #983.

Quantinno Capital Management first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Quantinno Capital Management held 296,251 shares of Teva Pharmaceuticals worth $10M as of Q2 2026.
Quantinno Capital Management bought 79,790 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.66M.
Teva Pharmaceuticals made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #983 holding.
Quantinno Capital Management first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.